1. Market Research
  2. > Biotechnology Market Trends
  3. > Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015

The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.

This second edition, includes:

Trends in joint venture deals
Joint venture agreement structure
Joint venture contract documents
Top joint venture deals by value
Most active joint venture dealmakers
Comprehensive directory of joint venture deals since 2010

This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.

The report provides details of joint venture agreements from 2010 to end of April 2015.

The report provides a detailed understanding and analysis of how and why companies enter joint venture deals.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all joint venture deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Report scope

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report is intended to provide the reader with an in-depth understanding of the joint venture trends and structure of deals entered into by leading biopharma companies worldwide.

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 includes:

Trends in joint venture dealmaking in the biopharma industry since 2010
Analysis of joint venture deal structure
Case studies of real-life joint venture deals
Access to over 450 joint venture deal records
Detailed access to actual joint venture contract documents
The leading joint venture deals by value since 2010
Most active joint venture dealmakers since 2010
The leading joint venture partnering resources

In Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015, the available contracts are listed by:

Company A-Z
Headline value
Stage of development at signing
Therapeutic area
Technology area

Each deal title links via Weblink to an online version of deal record as found in the Current Agreements deals and alliances database, providing easy access to each deal record on demand.

The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015 report provides comprehensive access to records for over 450 joint venture deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise joint venture rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement lawGlobal Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 provides the reader with the following key benefits:
In-depth understanding of joint venture deal trends since 2010
Analysis of the structure of joint venture agreements with numerous real life case studies
Comprehensive access to over 450 joint venture deals entered into by the world’s biopharma companies, together with contract documents if available
Detailed access to actual joint venture contracts entered into by the leading fifty big pharma and big biotech companies
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Identify leading joint venture deals by value since 2010
Identify the most active joint venture dealmakers since 2010
Full listing of joint venture deals by company A-Z, headline value, phase of development, deal type, therapy and technology focus

Table Of Contents

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in joint venture partnerships
2.1. Introduction
2.2. Definition of joint venture deals
2.3. Success factors for joint venture partnerships
2.4. When joint venture partnerships can be useful
2.5. Attributes of joint venture partnerships
2.6. Aligning partners to make the joint venture work
2.7. Trends in joint venture partnerships since 2010
2.8. The future of joint venture partnerships

Chapter 3 - Overview of joint venture deal structure
3.1. Introduction
3.2. Joint venture agreement structure
3.3. Example joint venture agreements
3.3.1. Case study 1: Agila Specialties - Pfenex - April 2013
3.3.2. Case study 2: Dance Biopharm - Harmony Asset - October 2013

Chapter 4 - Leading joint venture deals
4.1. Introduction
4.2. Top joint venture deals by value
4.3. Most active joint venture dealmakers
4.4. Big pharma joint venture deal activity
4.5. Big biotech joint venture deal activity

Chapter 5 - Big pharma joint venture deals
5.1. Introduction
5.2. How to use joint venture deals
5.3. Company joint venture agreement listings

Chapter 6 - Big biotech joint venture deals

6.1. Introduction
6.2. How to use joint venture deals
6.3. Company joint venture agreement listings

Chapter 7 - Joint venture contract directory 2010-2015

7.1. Introduction
7.2. Company A-Z
7.3. By therapy area
7.4. By stage of development at signing
7.5. By technology area

Appendix

Appendix 1 - Joint venture dealmaking - by company A-Z
Appendix 2 - Joint venture dealmaking - by stage of development
Appendix 3 - Joint venture dealmaking - by therapeutic target
Appendix 4 - Joint venture dealmaking - by technology type
Appendix 5 - Joint venture references
Appendix 6 - Resources
Appendix 7 - Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

For the entire list of company listing please contact enquiry@currentpartnering.com

TABLE OF FIGURES

Figure 1: Definition of joint venture
Figure 2: Situations where joint venture partnerships can prove useful
Figure 3: Key components of a joint venture partnership
Figure 4: Issues in implementing joint venture partnership agreements
Figure 5: Trends in joint venture deal announcements, 2010-2015
Figure 6: Joint venture deals signed at each phase of development, 2010-2015
Figure 7: Joint venture shareholder agreements - what should a contract include?
Figure 8: Components of the joint venture deal structure
Figure 9: Top joint venture deals by value since 2010
Figure 10: Most active joint venture dealmakers 2010-2015
Figure 11: Big pharma - top 50 - Joint venture deals 2010 to 2015
Figure 12: Bigpharma joint venture deal frequency - 2010 to 2015
Figure 13: Big biotech - top 50 - Joint venture deals 2010 to 2015
Figure 14: Big biotech joint venture deal frequency - 2010 to 2015
Figure 15: Online partnering resources
Figure 16: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • $ 18000
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, ...

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.